2025 annual financial data

Century Therapeutics, Inc. 2025 Operating margin

Century Therapeutics, Inc. 2025 operating margin with verified reported values.

Direct answer

Operating margin was -13.78%.

Operating income was -15,040,000 USD and net income was -9,580,000 USD.
Operating cash flow was -103,876,000 USD.

Get free Century Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
109,164,000 USD
Operating income
-15,040,000 USD
Net income
-9,580,000 USD
Operating cash flow
-103,876,000 USD